Show simple item record

FieldValueLanguage
dc.contributor.authorKaras, Pamela L.en
dc.contributor.authorRankin, Nicole M.en
dc.contributor.authorStone, Emilyen
dc.date.accessioned2020-07-27
dc.date.available2020-07-27
dc.date.issued2020en
dc.identifier.urihttps://hdl.handle.net/2123/22947
dc.description.abstractHealth professionals participating in multidisciplinary team (MDT) cancer meetings may not be aware of their medicolegal obligations. This commentary aims to identify medicolegal issues concerning multidisciplinary cancer care and provides recommendations for future implementation. Predominant medicolegal issues related to MDT care were identified in the literature and include: patient consent and privacy at MDT meeting, professional liability, formal expression of dissenting views, and duty of care. Analysis of the literature prioritises several recommendations for managing these issues. With limited precedent on which to base recommendations, this article identifies the formative evidence that may guide management of these issues in future MDT practice.en
dc.language.isoenen
dc.rightsOther
dc.subjectCOVID-19en
dc.subjectCoronavirusen
dc.titleMedicolegal Considerations in Multidisciplinary Cancer Careen
dc.typeArticleen
dc.identifier.doi10.1016/j.jtocrr.2020.100073
usyd.facultyFaculty of Medicine and Health, Sydney Medical Schoolen


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.